Navigation Links
Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results
Date:3/26/2009

(4,105) (13,098) Total stockholders' equity (deficit) 29,426 (12,295) Total liabilities and stockholders' equity (deficit) $69,889 $15,909 CORNERSTONE THERAPEUTICS INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) Year Ended December 31, 2008 2007 Cash flows from operating activities Net income $8,993 $570 Adjustments to reconcile net income to net cash provided by operating activities: Amortization and depreciation 1,425 3,231 Change in allowance for prompt payment discounts 221 38 Change in allowance for inventory obsolescence 476 101 Stock-based compensation 749 801 Loss on marketable security 8 323 Write-off of acquired in-process research and development 1,900 - Impairment of property and equipment 56 - Benefit for deferred income taxes (3,310) - Changes in operating assets and liabilities: Accounts receivable (5,050) (4,287) Amounts due from related parties - 117 Inventories (2,400) (1,252) Prepaid expenses (602) (12) Accounts payable 2,573 783 Accrued expenses 4,505 1,020 Income
'/>"/>
SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call
2. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
3. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
4. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009
5. Cell Therapeutics Announces Filing of Form 10-K
6. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
7. Oxygen Biotherapeutics, Inc. Expands Board of Directors
8. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
9. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
10. Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives
11. Medarex to Present at the Needham Cancer Therapeutics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... OTTAWA, Ontario , Jan. 14, 2014   Kinaxis ®, ... ( SCM ) and sales and operations planning ( S&OP ... the Biomanufacturing Summit , which will be held at ...  At the conference, join Kinaxis customer Elisabeth Kaszas , ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental ... about dual arch impressions on its dental blog. ... blog entry serves up a list of tips to help ... by Dr. David Little as he crafts a porcelain crown ...
(Date:1/14/2014)... 2014 Independent publisher Bitingduck Press, with ... Canada, has big ideas for 2014 in production and ... are to produce high-quality, low-cost, DRM-free ebooks and to ... , The first major development will be bookstore ...
Breaking Biology Technology:RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... 16 The landscape of scientific,publications strategy, planning ... guidelines. Half of global publications groups are fully,located ... a shift,to medical groups to increase clinical presentation, ... LLC., In a benchmarking study that included ...
... of international, multi-center registry presented at conference, ... BSX ) today announced that results from ... clinical utility,of the SpyGlass(R) Direct Visualization System will ... from May 17-22 in San Diego,CA. Registry results ...
... Products, L.P. Sponsors Program to Recognize Exemplary Work ... ... 16 CURE magazine announced the winner,and finalists of its ... the Oncology Nursing Society,s (ONS) 33rd Annual,Congress. Ortho Biotech Products, ...
Cached Biology Technology:Industry Executives Finding Value in Shift of Scientific Publications 2Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 2Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 3Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 4Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 5CURE Magazine Announces Winner of 2008 Extraordinary Healer Award 2
(Date:7/9/2014)... most numerous inhabitants of the sea: tiny haptophytes of ... the naked eye, when they are in bloom in ... even visible on satellite images. "Together with other phytoplankton, ... of the global photosynthesis output," states Prof. Dr. Georg ... the process the greenhouse gas carbon dioxide CO2 ...
(Date:7/8/2014)... 2014 Collectors found the first two specimens of the ... for two decades, the 14-inch-tall plant was identified wrongly as ... after a long search turned up a "pathetic, wilted" ... colleagues identified the spiny plant as a new, possibly endangered ... it was found in Valentine, Texas, population 134 in 2010. ...
(Date:7/8/2014)... greenhouse gases could be vulnerable to price spikes ... released by scholars affiliated with the Energy Institute ... prevent that outcome with three straightforward reforms, the ... Board should consider (1) strengthening the new market,s ... permits to be converted from one compliance period ...
Breaking Biology News(10 mins):Short circuit in the food web 2New plant species from the heart of Texas 2New plant species from the heart of Texas 3New plant species from the heart of Texas 4New plant species from the heart of Texas 5Three reforms to protect California's cap-and-trade policy 2
... human blood group that has remained a mystery for the past ... is responsible for the lack of this blood group in some ... blood group, medical scientists can now develop a more reliable DNA ... the risk of severe, and sometimes life threatening, destruction of the ...
... Florida State University College of Medicine has made discoveries ... how life first emerged on Earth billions of years ... supporting the idea that 10 amino acids believed to ... capable of forming foldable proteins in a high-salt (halophile) ...
... water quality studies to genetic counseling, the acquisition of ... opportunity to accelerate biological and medical research in the ... the George I. Alden Trust and a $10,000 award ... Erie Community Foundation, the Mercyhurst Biology Department has purchased ...
Cached Biology News:Final chapter to 60-year-old blood group mystery 2Final chapter to 60-year-old blood group mystery 3Researcher offers clues on the origins of life 2Researcher offers clues on the origins of life 3Mercyhurst University's new DNA sequencer to accelerate scientific research in region 2
...
These 22x40mm rectangular No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 73...
... Experion software, PC, is used to ... data obtained from the Experion automated ... in electropherogram and simulated gel views ... calculations in a Results table. This ...
...
Biology Products: